-
Technology
-
Industry
-
Solutions
-
- ASSET MANAGEMENT
- AUGMENTED & VIRTUAL REALITY
- COLLABORATION
- CONVERSATIONAL
- CUSTOMER EXPERIENCE MANAGEMENT
- CUSTOMER RELATIONSHIP MANAGEMENT
- CYBER SECURITY
- DATA CENTER
- DIGITAL CUSTOMER EXPERIENCE
- DOCUMENT MANAGEMENT
- EHS SOFTWARE
- ELECTRONIC DATA INTERCHANGE
- ENTERPRISE DATA MANAGEMENT
- ENTERPRISE DATA QUALITY MONITORING
- ENTERPRISE RESOURCE PLANNING
- ENTERPRISE RISK MANAGEMENT
- ENTERPRISE-GRADE WEB DATA SOLUTIONS
- FACILITY MANAGEMENT
- FIELD SERVICE
- GAMIFICATION
- IDENTITY AND ACCESS MANAGEMENT
- INFRASTRUCTURE
- IT SERVICE MANAGEMENT
- MANAGED IT SERVICES
- PAYMENT AND CARD
- PROJECT MANAGEMENT
- SOFTWARE TESTING
- STORAGE
- VIDEO SOLUTIONS
- WORKFLOW
-
-
Platforms
-
Functions
- Leadership Perspectives
- Innovation Insights
- Research
- Magazines
- News
- CXO Awards

NEW YORK: Tech giant IBM and New York Genome Center have decided to collaborate to study genetic data to speed up personalized, life-saving treatment for patients diagnosed with brain cancer. IBM's Watson cognitive computing system will be deployed to study genomic data from a small group of patients diagnosed with the most common malignancy recorded in the U.S. called glioblastoma.